• Главная
  • NEW DAY MEDICINE
  • 5 (91) 2026
  • 11 -5 (91) 2026 - G.S. Babadjanova, I.R. Saparbayeva - EFFECTIVENESS OF PRE-GRAVITY PREPARATION AND PROGNOSTIC VALUE OF BIOMARKERS IN WOMEN WITH A HISTORY OF SEVERE PREECLAMPSIA AND PYELONEPHRITIS

11 -5 (91) 2026 - G.S. Babadjanova, I.R. Saparbayeva - EFFECTIVENESS OF PRE-GRAVITY PREPARATION AND PROGNOSTIC VALUE OF BIOMARKERS IN WOMEN WITH A HISTORY OF SEVERE PREECLAMPSIA AND PYELONEPHRITIS

EFFECTIVENESS OF PRE-GRAVITY PREPARATION AND PROGNOSTIC VALUE OF BIOMARKERS IN WOMEN WITH A HISTORY OF SEVERE PREECLAMPSIA AND PYELONEPHRITIS

G.S. Babadjanova - Tashkent State Medical University

I.R. Saparbayeva - Tashkent State Medical University

Resume

The article presents the results of a study on the effectiveness of pre-pregnancy preparation in women of reproductive age. 110 women were examined and divided into 2 groups with a history of severe preeclampsia and pyelonephritis. A comparative analysis of the effectiveness of the preparation for pregnancy was conducted. Group I (n=65) included women with a history of severe preeclampsia; Group II (n=45) included women with a history of severe preeclampsia and pyelonephritis. The control group consisted of 30 apparently healthy women. Comprehensive preconception preparation prevented recurrence of preeclampsia and significantly reduced the incidence of premature birth and perinatal complications (p<0.05).

Key words: severe preeclampsia, pyelonephritis, pre-pregnancy preparation, Cystatin C, VEGF, perinatal complications.

First page

68

Last page

73

For citation:G.S. Babadjanova, I.R. Saparbayeva - EFFECTIVENESS OF PRE-GRAVITY PREPARATION AND PROGNOSTIC VALUE OF BIOMARKERS IN WOMEN WITH A HISTORY OF SEVERE PREECLAMPSIA AND PYELONEPHRITIS//New Day in Medicine 5(91)2026 68-73 https://newdayworldmedicine.com/en/new_day_medicine/5-91-2026

List of References

  1. Алдангарова ГА, и др. Новые возможности профилактики преэклампсии. Актуальные проблемы теоретической и клинической медицины. 2021;(1):89–91.
  2. Григорьева ОА, Беженарь ВФ. Хроническая болезнь почек и беременность: междисциплинарная оценка гестационных рисков и осложнений (обзор литературы). Журнал акушерства и женских болезней. 2023;72(1):71–80.
  3. Akinlade KS, Akinola RA, et al. High sensitivity C-reactive protein in pre-eclamptic women: a case-control study. Pan Afr Med J. 2024;48:136.
  4. Bayor F, Adu-Bonsaffoh K, Antwi-Boasiako C. Maternal serum angiopoietins levels in pre-eclampsia and pregnancy outcomes. Health Sci Rep. 2024;7(1):e1806. doi:10.1002/hsr2.1806.
  5. Bellos I, Fitrou G, Daskalakis G, Pergialiotis V. Serum cystatin C as predictive factor of preeclampsia: a meta-analysis of observational studies. J Matern Fetal Neonatal Med. 2019;32(18):3082–3090.
  6. Countouris ME, Nelson DB, Jeyabalan A. Relationship of postpartum cystatin C and high-sensitivity C-reactive protein levels with hypertensive disorders of pregnancy. Hypertens Res. 2019;42(10):1623–1630.
  7. American College of Obstetricians and Gynecologists. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin Summary, Number 222. Obstet Gynecol. 2020;135(6):1492–1495.

    file

    download